Scientific question of the day30 Sep 2020 13:12
Hi All but esp Rhubarb(Adam) & Grace and any other science majors,
In regard to 201 it is the ability to act upon the cancer causing elements specifically (was it SrC inhibition?) that make this able to work without the wider side effects. About a month ago there was also talk of this being appliccable to Female cancers such as Breast and Ovarian (the one I have lost people to more than any other). Is that simple hypothesis that it would have effect on many forms of cancer fanciful or not?
Reason to ask is that if so and with knowledge of 50% effective in trial and lower side-effects does VAL201 not send a shock wave through the whole Oncology drug arena?
If thats yes, then we are getting excited about shiny baubles - wouldnt an existing Oncology drug major want to buy the lot to get patents?
I have obviously made this ultra simple, but hey, its a dogs life to see in black and white only...